- Home
- FDSB vs BDTX Comparison
FDSB vs BDTX Comparison
Compare FDSB & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDSB
- BDTX
- Stock Information
- Founded
- FDSB 1926
- BDTX 2014
- Country
- FDSB United States
- BDTX United States
- Employees
- FDSB N/A
- BDTX N/A
- Industry
- FDSB
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FDSB
- BDTX Health Care
- Exchange
- FDSB NYSE
- BDTX Nasdaq
- Market Cap
- FDSB 69.2M
- BDTX 132.5M
- IPO Year
- FDSB N/A
- BDTX 2020
- Fundamental
- Price
- FDSB $12.25
- BDTX $2.41
- Analyst Decision
- FDSB
- BDTX Strong Buy
- Analyst Count
- FDSB 0
- BDTX 5
- Target Price
- FDSB N/A
- BDTX $15.60
- AVG Volume (30 Days)
- FDSB 13.5K
- BDTX 1.4M
- Earning Date
- FDSB 08-15-2025
- BDTX 08-05-2025
- Dividend Yield
- FDSB N/A
- BDTX N/A
- EPS Growth
- FDSB N/A
- BDTX N/A
- EPS
- FDSB 0.02
- BDTX 0.09
- Revenue
- FDSB $12,612,000.00
- BDTX $70,000,000.00
- Revenue This Year
- FDSB N/A
- BDTX N/A
- Revenue Next Year
- FDSB N/A
- BDTX N/A
- P/E Ratio
- FDSB $515.94
- BDTX $27.30
- Revenue Growth
- FDSB 40.41
- BDTX N/A
- 52 Week Low
- FDSB $9.85
- BDTX $1.20
- 52 Week High
- FDSB $14.50
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- FDSB N/A
- BDTX 57.88
- Support Level
- FDSB N/A
- BDTX $2.15
- Resistance Level
- FDSB N/A
- BDTX $2.71
- Average True Range (ATR)
- FDSB 0.00
- BDTX 0.17
- MACD
- FDSB 0.00
- BDTX -0.01
- Stochastic Oscillator
- FDSB 0.00
- BDTX 55.36
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.